Mikael Dolsten - Articles and news items

Pfizer logo

Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration

Industry news / 19 June 2014 / Pfizer

Pfizer Inc. and Cellectis announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets…

Pfizer logo

Pfizer opens new state-of-the-art Research and Development Site in Cambridge, Massachusetts

Industry news / 16 June 2014 / Pfizer

Pfizer Inc. announced the opening of a new 280,000 square-foot Research and Development hub in Cambridge, Mass…

Pfizer logo

Pfizer to acquire Excaliard Pharmaceuticals

Industry news, News / 22 November 2011 / Pfizer

Lead program includes novel investigational compound for prevention/treatment of skin scarring…

Pfizer logo

Pfizer and MIT break ground on new research units in Kendall Square

Industry news, News / 21 November 2011 / Pfizer

10-year lease marks a strategic partnership between the academic research community and industry to boost innovation…

Pfizer logo

Pfizer invites public to view and listen to webcast of Pfizer presentation at Healthcare Conference

Industry news, News / 10 March 2011 / Pfizer

View and listen to a webcast of a presentation by Mikael Dolsten, President, Worldwide R&D…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...